Immediate Impact
26 standout
Citing Papers
Digestive cancers: mechanisms, therapeutics and management
2025 Standout
Hepatocellular carcinoma: signaling pathways and therapeutic advances
2025 Standout
Works of Michelle Marcovitz being referenced
Patient-reported outcomes from the phase 3 HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma.
2022
MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer
2022
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Michelle Marcovitz | 81 | 64 | 72 | 6 | 152 | |
| Kadzuki Nakabayashi | 30 | 35 | 93 | 6 | 200 | |
| Kalpana Devaraj | 62 | 64 | 36 | 8 | 210 | |
| Gaël Goujon | 149 | 70 | 70 | 10 | 192 | |
| M. Flubacher | 46 | 27 | 55 | 7 | 181 | |
| Tracy Jiezhen Loh | 92 | 69 | 65 | 9 | 154 | |
| Chimela Ohaji | 78 | 62 | 41 | 8 | 159 | |
| Francesc Pons | 40 | 63 | 32 | 8 | 153 | |
| Petra Jankowska | 34 | 30 | 24 | 6 | 136 | |
| Annick Chevalier-Place | 53 | 27 | 45 | 7 | 142 | |
| Hélène Bonte | 20 | 74 | 12 | 9 | 177 |
All Works
Login with ORCID to disown or claim papers
Loading papers...